Tikva Allocell
News,Biotech / MedTech,Singapore
Singapore’s Tikva Allocell raises $8M in Series A financing led by Kantharos Capital
Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.
July 23, 2026
Hong Kong fintech Reap launches managed fraud service for card programs
September 21, 2026
India’s Moneyview seeks up to $624M valuation in trimmed IPO
September 21, 2026
Singapore’s MetaOptics secures up to $10M US investment facility
September 21, 2026
Global humanoid robot sales reached about 7,000 in 2025: IFR
September 21, 2026
Hong Kong fintech Reap launches managed fraud service for card programs
September 21, 2026
India’s Moneyview seeks up to $624M valuation in trimmed IPO
September 21, 2026
Singapore’s MetaOptics secures up to $10M US investment facility
September 21, 2026
Global humanoid robot sales reached about 7,000 in 2025: IFR
September 21, 2026




